Stanozolol , 98% , 10418-03-8

Synonym(s):
17β-Hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole;5α-Androstane-17α-methyl-17β-ol-[3,2-c]pyrazole;Androstanazole;Stanazol

CAS NO.：10418-03-8

Empirical Formula: C21H32N2O

Molecular Weight: 328.49

MDL number: MFCD00133084

EINECS: 233-894-8

PRODUCT Properties

• Melting point: 242 °C
• Boiling point: 490.8±45.0 °C(Predicted)
• alpha: 34 º
• Density: 1.129±0.06 g/cm3(Predicted)
• refractive index: 34 ° (C=0.4, CHCl3)
• Flash point: -2℃
• storage temp.: 2-8°C
• solubility: Practically insoluble in water, soluble in dimethylformamide, slightly soluble in ethanol (96 per cent), very slightly soluble in methylene chloride.
• form: powder
• pka: 15.15±0.60(Predicted)
• color: white to light yellow
• Merck: 8794
• InChIKey: LKAJKIOFIWVMDJ-IYRCEVNGSA-N

Description and Uses

Stanozolol (Item No. 21167) is an analytical reference standard that is categorized as a synthetic anabolic androgenic steroid. Stanozolol has low urinary excretion; therefore, its metabolites are usually used for detection. Formulations containing stanozolol are used as a treatment for hereditary angioedema. It has also been abused in athletics to improve performance. Stanozolol is regulated as a Schedule III compound in the United States. This product is intended for research and forensic applications.

Anabolic steroid. Androgen. Controlled substance.

Safety

• Symbol(GHS): GHS08
• Signal word: Danger
• Hazard statements: H351-H360FD
• Precautionary statements: P201-P202-P280-P308+P313-P405-P501
• Hazard Codes: Xn,Xi,T,F
• Risk Statements: 63-38-19-11-61-60
• Safety Statements: 53-22-36/37/39-36-26-45
• RIDADR: UN2252 - class 3 - PG 2 - 1,2-Dimethoxyethane solution
• WGK Germany: 3
• RTECS: BV8741000
• HS Code: 29372900